Miami International GC sells 44K shares at $40.49
MIAMI INTERNATIONAL HOLDINGS, INC.
Rhea-AI Filing Summary
MIAMI INTERNATIONAL HOLDINGS, INC. (MIAX) reported that executive vice president, general counsel and corporate secretary Barbara J. Comly exercised options for 44,445 shares of common stock at an exercise price of $12.00 per share on September 2, 2026, and sold the same number of shares at a weighted average price of $40.49 per share, pursuant to a previously established Rule 10b5-1 trading plan.
The option exercise reduced her position in the related option grant by 44,445 options, leaving 44,444 options of that grant outstanding and fully vested, with an expiration date of May 28, 2028.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and Sale: 44,445 shares ($1.27M approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
Comly Barbara J.
Role
EVP, GC & Corporate Secretary
Sold
44,445 shs ($1.80M)
Approx. gross sale proceeds
$1.80M
Approx. exercise cost
$533K
Approx. pre-tax spread
$1.27M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Nonqualified Stock Option (Right to Buy) F1, F3 | 44,445 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 44,445 | $12.00 | $533K |
| Sale | Common Stock F1, F2 | 44,445 | $40.49 | $1.80M |
Holdings After Transaction:
Nonqualified Stock Option (Right to Buy) — 44,444 contracts (Direct);
Common Stock — 839,564 shares (Direct)
Footnotes (3)
- F1. This transaction was effected pursuant to a previously established Rule 10b5-1 Plan adopted by the Reporting Person on December 18, 2025.
- F2. This transaction was executed in multiple trades throughout the day at prices ranging from $39.66 to $41.80. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- F3. The options are fully vested.
Key Figures
Shares underlying options exercised: 44,445 shares
Option exercise price: $12.00 per share
Shares of common stock sold: 44,445 shares
+5 more
8 metrics
Shares underlying options exercised
44,445 shares
Nonqualified stock options for MIAX common stock exercised on September 2, 2026
Option exercise price
$12.00 per share
Exercise price for 44,445 nonqualified stock options exercised on September 2, 2026
Shares of common stock sold
44,445 shares
MIAX common shares sold on September 2, 2026 after option exercise
Weighted average sale price
$40.49 per share
Weighted average price for 44,445 MIAX shares sold in multiple trades on September 2, 2026
Sale price range
$39.66 to $41.80 per share
Price range of multiple trades comprising the 44,445-share sale on September 2, 2026
Options remaining from this grant
44,444 options
Nonqualified stock options reported as held directly after the exercise on September 2, 2026
Option expiration date
May 28, 2028
Expiration date for the nonqualified stock options related to the reported exercise
Rule 10b5-1 plan adoption date
December 18, 2025
Date Barbara J. Comly adopted the trading plan governing these transactions
Key Terms
Nonqualified Stock Option, Rule 10b5-1 Plan, weighted average sales price
3 terms
Nonqualified Stock Option financial
"The filing reports the exercise of a Nonqualified Stock Option to buy MIAX common stock."
A nonqualified stock option (NQSO) is a company grant that gives an individual the right to buy shares at a set price but does not meet special tax rules for incentive stock options; when exercised the difference between the market price and the exercise price is treated as ordinary income for the recipient and as a tax-deductible expense for the company. It matters to investors because NQSOs affect an employee’s after-tax proceeds, the company’s reported expenses, and potential share dilution—think of it like a cash bonus that converts into stock but is taxed as regular pay when you take it.
Rule 10b5-1 Plan regulatory
"A footnote states the trades were effected under a previously established Rule 10b5-1 Plan."
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average sales price financial
"The price reported reflects the weighted average sales price for the shares sold."
FAQ
What did MIAX executive Barbara J. Comly report in this Form 4 for MIAX?
She reported exercising 44,445 options for MIAX common stock at $12.00 per share and selling 44,445 shares at a weighted average price of $40.49 per share on September 2, 2026, under a previously adopted Rule 10b5-1 trading plan.
What options did Barbara J. Comly exercise in this MIAX Form 4 filing?
She exercised 44,445 nonqualified stock options to buy MIAX common stock at an exercise price of $12.00 per share on September 2, 2026. The options are reported as fully vested and are scheduled to expire on May 28, 2028.
Were Barbara J. Comly’s MIAX transactions under a Rule 10b5-1 plan?
Yes. A footnote states that the reported transactions on September 2, 2026 were effected pursuant to a previously established Rule 10b5-1 Plan adopted by Barbara J. Comly on December 18, 2025.
How many MIAX options from this grant does Barbara J. Comly hold after these transactions?
After exercising 44,445 options from this grant, she is reported as holding 44,444 options of the same nonqualified stock option grant directly, with those options fully vested and expiring on May 28, 2028.
Does the Form 4 state how the MIAX sale price range was determined?
Yes. The filing explains that the sale was executed in multiple trades at prices ranging from $39.66 to $41.80, and that the reported $40.49 figure is the weighted average sales price for the reported 44,445 shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.